Clinical Trial

AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration

Name: AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration — clinical trial record (NCT07725055)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RETION

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Primary objective: \- Acquisition and analysis of images for non-medical purposes using the MONA IV system, an adaptive-optics-corrected scanning ophthalmoscope. Secondary objectives: * To measure the reproducibility of assessments; * To evaluate the detection of progressive changes.

Trial Details

NCT Number	NCT07725055
Lead Sponsor	Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Conditions	Glaucoma Associated With Other Ocular Disorders, Retina Disorder
Enrollment	260 participants
Start Date	2026-09
Primary Completion	2026-09 (estimated)
Study Completion	2030-04 (estimated)
Updated on ClinicalTrials.gov	2026-07-24